Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 52,334 | 0 | 0 | N/A | 0 |
| Other current assets | 4,071 | 0 | 0 | 0 | 0 |
| TOTAL | $56,745 | $0 | $0 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 31 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 561 | 0 | 0 | 0 | 0 |
| TOTAL | $592 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $57,336 | $0 | $0 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,510 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 5,847 | 0 | 0 | N/A | 0 |
| TOTAL | $9,584 | $0 | $0 | $N/A | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 358 | 0 | 0 | 0 | 0 |
| TOTAL | $358 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $9,943 | $0 | $0 | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,050 | N/A | N/A | N/A | N/A |
| Common Shares | 1 | 0 | 0 | N/A | 0 |
| Retained earnings | -77,456 | 0 | 0 | N/A | 0 |
| Other shareholders' equity | 104,501 | 0 | 0 | 0 | 0 |
| TOTAL | $47,393 | $0 | $0 | $N/A | $0 |
| Total Liabilities And Equity | $57,336 | $0 | $0 | $0 | $0 |